Burst calculations for 252Cf brachytherapy sources.
Due to helium production following alpha decay, it is necessary to demonstrate the structural integrity of new 252Cf sources at elevated temperatures for special form certification by the U.S. Department of Transportation. Effects of temperature, capsule composition, and capsule dimensions are examined and reduced to a simple mathematical model. This highly conservative model assumes that all gas products leaving the radioactive source wire are retained by the capsule, and upon elevation to a temperature of 800 degrees C the capsule exhibits negligible expansion or change in internal volume and no increase in gas-phase components due to vaporization of spontaneous fission products. The calculated maximum loadings for the ORNL-made Applicator Tube and three proposed high dose rate 252Cf sources encapsulated in Pt/Ir-10% (VariSource, microSelectron classic, and a novel design) were 10.8, 0.508, 0.708, and 2.12 mg 252Cf, respectively.
Rivard
M J
MJ
Department of Radiation Oncology, Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts 02111, USA. mrivard@lifespan.org
D001918:Brachytherapy / Q000295:instrumentation* / Q000379:methods*; D002142:Californium / Q000378:metabolism / Q000627:therapeutic use*; D006371:Helium; D008962:Models, Theoretical; D011868:Radioisotopes / Q000378:metabolism / Q000627:therapeutic use; D013696:Temperature; D013997:Time Factors
D011868:Radioisotopes; D006371:Helium; D002142:Californium